Indian pharma firms trail global peers in R&D, innovation, and talent metrics: FAST India-IIFL Securities

FibroBiologics has entered a master services agreement with Charles River Laboratories to develop and manufacture cell-based therapies for chronic diseases. The agreement will involve the manufacture ...

PARIS ― The French government said Sunday it is backing the sale of a subsidiary of pharmaceuticals multinational Sanofi that produces over-the-counter drugs to American private equity firm CD&R aft...

On Friday, Novo Nordisk A/S said that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending approval of...

Zolbetuximab-clzb (Vyloy; Astellas Pharma Inc) was granted FDA approval for the treatment of patients with locally advanced unresectable or metastatic human epidermal growth factor receptor 2-...